ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Policy

Former FDA chief Gottlieb joins Pfizer board

by Lisa M. Jarvis
July 5, 2019 | APPEARED IN VOLUME 97, ISSUE 27

 

Former US Food and Drug Administration commissioner Scott Gottlieb, who returned to the private sector in April, has joined the board of Pfizer. Gottlieb received largely favorable reviews for his 2-year stint as FDA chief but is being criticized harshly for this latest role. Last week, Sen. Elizabeth Warren called on him to resign from Pfizer’s board, noting in a letter to Gottlieb that the role “is exactly the kind of ‘revolving door influence-peddling’ that causes Americans to lose faith in government.” A number of former FDA commissioners similarly have gone on to advise or serve on the boards of drug companies.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment